deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00767624

TRIAD - Treatment of Insomnia and Depression

Improving Depression Outcome by Adding Insomnia Therapy to Antidepressants

Sponsor: Duke University

Conditions Depression Sleep Initiation and Maintenance Disorders
Interventions Antidepressant Cognitive Behavioral Therapy for Insomnia Desensitization Therapy for Insomnia
Updated 8 times since 2017 Last updated: Oct 10, 2016 Started: Dec 31, 2008 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00767624, this PHASE2/PHASE3 trial focuses on Depression and Sleep Initiation and Maintenance Disorders and remains completed. Sponsored by Duke University, it has been updated 8 times since 2008, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2_PHASE3

  5. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE2_PHASE3

▶ Show 3 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2_PHASE3

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  3. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
  • Stanford University
  • University of Pennsylvania
  • University of Pittsburgh
Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations